<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Hickey Saleh | Activity</title>
	<link>https://www.catswannabecats.com/members/celeryanger76/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/celeryanger76/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hickey Saleh.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7c60846540f9146d2066cdff44231dd5</guid>
				<title>Hickey Saleh posted an update: This work aims at fabricating 5-fluorouracil (5-FU)-loaded [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22140/</link>
				<pubDate>Sat, 07 Jun 2025 08:17:50 -0400</pubDate>

									<content:encoded><![CDATA[<p>This work aims at fabricating 5-fluorouracil (5-FU)-loaded poly (lactic-co-glycolic) acid nanoparticles (PLGA NPs) using a microfluidic (MF) technique, with potential for use in colorectal cancer therapy. In order to achieve 5-FU-loaded NPs with an average diameter of approximately 119 nm, the parameters of MF process with fork-shaped patterns&hellip;<span class="activity-read-more" id="activity-read-more-22140"><a href="https://www.catswannabecats.com/activity/p/22140/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">73eb15d747a72067a55154efe8e49c2d</guid>
				<title>Hickey Saleh posted an update: To inform prevention efforts, we sought to determine which [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11849/</link>
				<pubDate>Sun, 01 Jun 2025 08:18:10 -0400</pubDate>

									<content:encoded><![CDATA[<p>To inform prevention efforts, we sought to determine which cancer types contribute the most to cancer mortality disparities by individual-level education using national death certificate data for 2017.</p>
<p> Information on all US deaths occurring in 2017 among 25-84-year-olds was ascertained from national death certificate data, which include&hellip;<span class="activity-read-more" id="activity-read-more-11849"><a href="https://www.catswannabecats.com/activity/p/11849/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">40df304bb22cea221db5373aab7802a0</guid>
				<title>Hickey Saleh posted an update: Cell-free DNA (cfDNA) profiling is increasingly used to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2893/</link>
				<pubDate>Sat, 31 May 2025 09:30:35 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cell-free DNA (cfDNA) profiling is increasingly used to guide cancer care, yet mutations are not always identified. The ability to detect somatic mutations in plasma depends on both assay sensitivity and the fraction of circulating DNA in plasma that is tumor-derived (i.e., cfDNA tumor fraction). We hypothesized that cfDNA tumor fraction could&hellip;<span class="activity-read-more" id="activity-read-more-2893"><a href="https://www.catswannabecats.com/activity/p/2893/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">59456063f84a75c777182a1380495b0b</guid>
				<title>Hickey Saleh became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/2795/</link>
				<pubDate>Sat, 31 May 2025 09:17:09 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>